Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Ischemic Heart Disease

Free Subscription Articles published in Can J Cardiol Retrieve available abstracts of 123 articles: HTML format

Single Articles

July 2026
1. AYTEKIN A, Voll F, Simonetti F, Blum E, et al
   Clinical and Angiographic Outcomes Following Percutaneous Treatment of Chronic Totally Occluded Versus Non-Totally Occluded Coronary Vessels.
   Can J Cardiol. 2026;42:1490-1501.
   PubMed     Abstract available
   
   
   
2. RAZAVI AA, Sallam A, Lim B, Sharew B, et al
   Reevaluating Internal Thoracic Artery Use in Octogenarians Undergoing Multivessel Coronary Artery Bypass Grafting.
   Can J Cardiol. 2026;42:1665-1672.
   PubMed     Abstract available
   
   
   June 2026
3. KAY RT, Perka J, Sidhu A, Zheng Y, et al
   Impact of Baseline Q Waves and Reperfusion Strategy on Outcomes in ST-elevation Myocardial Infarction: Insights from the Vital Heart Response Registry.
   Can J Cardiol. 2026 Jun 23:S0828-282X(26)00635.
   PubMed     Abstract available
   
   
   
4. ZHANG M
   Methodological considerations regarding angio-index of microcirculatory resistance prognosis after acute myocardial infarction.
   Can J Cardiol. 2026 Jun 6:S0828-282X(26)00523-4. doi: 10.1016/j.cjca.2026.
   PubMed    
   
   
   
5. BOIVIN-PROULX LA, Schampaert E, Bainey K, Chong AY, et al
   Defining Population at Risk and Assessment of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction.
   Can J Cardiol. 2026;42:1158-1168.
   PubMed     Abstract available
   
   
   
6. BOIVIN-PROULX LA, Schampaert E, Bainey K, Chong AY, et al
   A Standardized Invasive Protocol for the Investigation of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction.
   Can J Cardiol. 2026;42:1181-1189.
   PubMed     Abstract available
   
   
   
7. BOIVIN-PROULX LA, Schampaert E, Bainey K, Chong AY, et al
   Defining Metrics and the Framework for the Invasive Assessment of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction.
   Can J Cardiol. 2026;42:1169-1180.
   PubMed     Abstract available
   
   
   
8. BOGNER E, Har B, Li B, Southern DA, et al
   Comprehensive Machine Learning-Enabled Outcome Prediction for Patients With Coronary Artery Disease Using Multicentre Patient Data.
   Can J Cardiol. 2026;42:1384-1396.
   PubMed     Abstract available
   
   
   
9. MANTELLA LE, Colledanchise KN, Liblik K, Hetu MF, et al
   Carotid Plaque Border Ulceration is Associated With Coronary Artery Disease and Future Cardiovascular Events.
   Can J Cardiol. 2026;42:1237-1246.
   PubMed     Abstract available
   
   
   
10. SU Y, Mei J, Ye R, Pan X, et al
    Predicting Midterm Risk of Coronary Plaque Progression in Subclinical Nonobstructive Coronary Atherosclerosis Using Explainable Machine Learning.
    Can J Cardiol. 2026;42:1140-1157.
    PubMed     Abstract available
    
    
    
11. ZHANG M, Zou Y, Ruan H, Chen Y, et al
    Activation of Endothelial TRPV4 Exacerbates Myocardial Ischemia-Reperfusion Injury via Vascular Integrity Impairment.
    Can J Cardiol. 2026;42:1353-1365.
    PubMed     Abstract available
    
    
    May 2026
12. WANG J, Gao W, Wang Z, Zhang F, et al
    Dynamic Changes and Prognostic Value of Angio-derived Index of Microcirculatory Resistance in Acute Myocardial Infarction: A Cohort Study.
    Can J Cardiol. 2026 May 13:S0828-282X(26)00406.
    PubMed     Abstract available
    
    
    
13. RUEL M, Chong AY, Grudzinski AL, Pritchard K, et al
    Stop the Invasion-Advances in Myocardial Revascularization.
    Can J Cardiol. 2026;42.
    PubMed     Abstract available
    
    
    
14. BOIVIN-PROULX LA, So DYF, Tulloch H, Heshka J, et al
    A Woman's Heart: The Microvascular Disease Dilemma.
    Can J Cardiol. 2026;42.
    PubMed     Abstract available
    
    
    
15. MCPHERSON R
    Genetics and Genomics of Coronary Artery Disease: What We Have Learned.
    Can J Cardiol. 2026;42.
    PubMed     Abstract available
    
    
    April 2026
16. KAVSAK PA, Pickering JW, Strauss B, Greenslade JH, et al
    External validation of a universal laboratory pathway for early risk-stratification of myocardial infarction in the emergency setting.
    Can J Cardiol. 2026 Apr 28:S0828-282X(26)00380.
    PubMed    
    
    
    
17. DI GIOIA G, Ferrone M, Franco D, Russo M, et al
    Clinical outcomes of Sirolimus coated balloons for the treatment of coronary disease. The Metal-Free registry.
    Can J Cardiol. 2026 Apr 21:S0828-282X(26)00363.
    PubMed     Abstract available
    
    
    
18. SUBHERWAL NG, Subherwal SP, Kim J, Sternfeld D, et al
    A Unique Case of Methemoglobinemia Presenting With ST Elevation Myocardial Infarction, Shock, and Left Ventricular Dysfunction.
    Can J Cardiol. 2026 Apr 20:S0828-282X(26)00359.
    PubMed    
    
    
    
19. WU S, Wang S, Xu F, Pang J, et al
    High Kidney Function in Myocardial Infarction Patients Undergoing Coronary Intervention: Risk of Acute Kidney Injury Risk and Long-term Prognosis.
    Can J Cardiol. 2026 Apr 13:S0828-282X(26)00354.
    PubMed     Abstract available
    
    
    
20. DOMA M, Ramadan A, Cogar B, McEntegart MB, et al
    Percutaneous Coronary Intervention for Chronic Total Occlusion in Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Can J Cardiol. 2026 Apr 6:S0828-282X(26)00297-7. doi: 10.1016/j.cjca.2026.
    PubMed    
    
    
    
21. RANGE G, Cayla G, Angoulvant D, Morelle JF, et al
    Impact of P2Y12 Inhibitors Pretreatment on Stent Thrombosis in Patients Undergoing Percutaneous Coronary Intervention: Insight France PCI Registry.
    Can J Cardiol. 2026;42:689-698.
    PubMed     Abstract available
    
    
    March 2026
22. FIORI E, Dierckx R, Dauw J, Heggermont W, et al
    Right Ventricular Failure Secondary to Delayed Ventricular Septal Rupture After Myocardial Infarction in a Left Ventricular Assist Device Recipient.
    Can J Cardiol. 2026 Mar 27:S0828-282X(26)00285.
    PubMed    
    
    
    
23. GUO J, Zhang P
    Do Beta-Blockers Still Benefit Patients After Myocardial Infarction Without Heart Failure?
    Can J Cardiol. 2026 Mar 6:S0828-282X(26)00244-8. doi: 10.1016/j.cjca.2026.
    PubMed    
    
    
    February 2026
24. ZEITOUNI M, Montalescot G, Roule V, Guedeney P, et al
    Definition and prediction of periprocedural myocardial infarction in elective percutaneous coronary intervention: the ALPHEUS-MI study.
    Can J Cardiol. 2026 Feb 26:S0828-282X(26)00140.
    PubMed     Abstract available
    
    
    
25. KAWTHARANY H, Rayyan A, Mestarihi A, Hamarsha Q, et al
    Beta-Blockers in Patients with Myocardial Infarction and No Heart Failure: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
    Can J Cardiol. 2026 Feb 26:S0828-282X(26)00157.
    PubMed     Abstract available
    
    
    
26. WANG L, Zhao X, Fan Y, Peng L, et al
    3D Cardiac Magnetic Resonance Substrate Features-Based Machine Learning Model for Post-myocardial Infarction Risk Stratification: a Multicenter Study.
    Can J Cardiol. 2026 Feb 20:S0828-282X(26)00145.
    PubMed     Abstract available
    
    
    
27. DAVID P, Roquero P, Coutance G
    New Insights Into Pathogenesis, Diagnosis, and Management of Cardiac Allograft Vasculopathy.
    Can J Cardiol. 2026;42:335-345.
    PubMed     Abstract available
    
    
    December 2025
28. HASSANABAD AF, Fedak PWM, Deniset JF
    Myocardial Infarction Elicits a Robust Inflammatory Response in the Pericardial Space.
    Can J Cardiol. 2025 Dec 26:S0828-282X(25)01604.
    PubMed    
    
    
    
29. SONG JE, Yang HM, Kang J, Hwang D, et al
    Long-Term Clopidogrel vs Aspirin Monotherapy in coronary artery disease patients with High Ischemic Risk: HOST-EXAM Extended Study Post Hoc Analysis.
    Can J Cardiol. 2025 Dec 24:S0828-282X(25)01576.
    PubMed     Abstract available
    
    
    
30. BELLEY-COTE EP, Whitlock RP, Lamy A, Alhussein MM, et al
    Association Between Electrocardiographic Changes and Myocardial Injury or Death After Cardiac Surgery.
    Can J Cardiol. 2025;41:2601-2610.
    PubMed     Abstract available
    
    
    
31. LIU Y, Zhou Y, Lin X, Zeng L, et al
    Postprocedural Parenteral Anticoagulation in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
    Can J Cardiol. 2025;41:2509-2519.
    PubMed     Abstract available
    
    
    
32. LIU M, Du Y, Cui C, Li C, et al
    Distal Radial Artery Access With 6F and 7F Thin-Walled Sheaths for Coronary Intervention: A Multicentre, Randomized, DRAWS Trial Protocol.
    Can J Cardiol. 2025;41:2420-2428.
    PubMed     Abstract available
    
    
    
33. BACK M, Leosdottir M, James S, Hagstrom E, et al
    Cardiac Rehabilitation Registries as Tools for Quality Improvement and Research: Insights From the SWEDEHEART-CR registry.
    Can J Cardiol. 2025;41.
    PubMed     Abstract available
    
    
    November 2025
34. OKA S, Takemura K, Takefuji Y
    Feature Importance Bias: Addressing Interpretability Issues in Tree-Based Acute Myocardial Infarction Risk Models.
    Can J Cardiol. 2025 Nov 27:S0828-282X(25)01475.
    PubMed    
    
    
    
35. MAHAJAN K, Rana V
    Enhancing Clinical Relevance of AI-Based Risk Prediction in Acute Myocardial Infarction.
    Can J Cardiol. 2025 Nov 1:S0828-282X(25)01299-1. doi: 10.1016/j.cjca.2025.
    PubMed    
    
    
    
36. PU X, Peng Y, Zhou X, Yang P, et al
    Development and Validation of a Nomogram for Predicting Intravenous Immunoglobulin-Responsive Coronary Progression in Kawasaki Disease.
    Can J Cardiol. 2025;41:2275-2287.
    PubMed     Abstract available
    
    
    October 2025
37. MCALISTER C, Kang M, Alfadhel M, Samuel R, et al
    Thrombolysis in Spontaneous Coronary Artery Dissection - Angiographic Findings and Clinical Outcomes.
    Can J Cardiol. 2025 Oct 29:S0828-282X(25)01287.
    PubMed     Abstract available
    
    
    
38. ZORDOK M, Al-Azizi K, Szerlip M, Basir MB, et al
    Cardiogenic Shock in Takotsubo vs. Acute Myocardial Infarction: Insights from The National Readmission Database 2016-2022.
    Can J Cardiol. 2025 Oct 16:S0828-282X(25)01201.
    PubMed     Abstract available
    
    
    
39. IZUMI A, Yau TM, Fedak PWM, Fatehi Hassanabad A, et al
    Pericardial Delivery of Stem Cells: An Emerging Frontier in Myocardial Regeneration for Ischemic Heart Disease.
    Can J Cardiol. 2025 Oct 14:S0828-282X(25)01214.
    PubMed     Abstract available
    
    
    
40. SHIH AW, Schnell G, Belley-Cote E, Lett R, et al
    Canadian Cardiovascular Society and National Advisory Committee on Blood and Blood Products Joint Statement on Blood Utilization and Transfusion for Patients With Acute Coronary Syndromes.
    Can J Cardiol. 2025;41:1875-1884.
    PubMed     Abstract available
    
    
    
41. WANG K, Sharir T, Hauser MT, Dorbala S, et al
    Reassessing Cardiovascular Risk in Patients With Peripheral Artery Disease Undergoing Myocardial Perfusion Imaging.
    Can J Cardiol. 2025;41:1936-1945.
    PubMed     Abstract available
    
    
    
42. SCOTT M, Kyriakopoulos CP, Sheffield E, Krauspe E, et al
    Application of the Updated Cardiogenic Shock Working Group SCAI Classification for Cardiogenic Shock: A Single-Centre Analysis.
    Can J Cardiol. 2025;41:2053-2063.
    PubMed     Abstract available
    
    
    September 2025
43. GHAFFAR MD, Javed MU
    Reassessing the Clinical Applicability of Artificial Intelligence Driven Risk Models in Acute Myocardial Infarction.
    Can J Cardiol. 2025 Sep 27:S0828-282X(25)01188.
    PubMed    
    
    
    
44. CAI D, Sun T, Wei J, Deng L, et al
    Explainable Artificial Intelligence-Driven Risk Assessment for Malignant Ventricular Arrhythmia and Mortality in Acute Myocardial Infarction.
    Can J Cardiol. 2025 Sep 17:S0828-282X(25)01167.
    PubMed     Abstract available
    
    
    
45. MALIK MI, Lou W, Bisleri G, Connelly K, et al
    Machine Learning Reveals How Depression Influences Chest Pain Localization and Its Predictive Value for Coronary Artery Disease.
    Can J Cardiol. 2025 Sep 17:S0828-282X(25)01169.
    PubMed     Abstract available
    
    
    August 2025
46. WONG HJ, Low CE, Yau CE, Teo YH, et al
    Optimization of Guideline-Directed Medical Therapy Prescription after First-onset Myocardial Infarction in the Very Elderly.
    Can J Cardiol. 2025 Aug 22:S0828-282X(25)01035.
    PubMed    
    
    
    
47. SHI J
    Improving Guideline Therapy Assessment After First Myocardial Infarction in the Very Elderly Population.
    Can J Cardiol. 2025 Aug 11:S0828-282X(25)00659.
    PubMed    
    
    
    
48. HAYES SN, Gulati R
    Navigating Therapeutic Ambiguity: Thrombolysis in Spontaneous Coronary Artery Dissection Presenting As ST-Segment Elevation Myocardial Infarction.
    Can J Cardiol. 2025 Aug 4:S0828-282X(25)00648-8. doi: 10.1016/j.cjca.2025.
    PubMed    
    
    
    
49. SHENG Z, Che W, An S, Zhang Z, et al
    Assessing Coronary Microvascular Dysfunction Using Angiographic Frame Count in Patients With Angina and Nonobstructive Coronary Arteries.
    Can J Cardiol. 2025;41:1446-1455.
    PubMed     Abstract available
    
    
    
50. POLETTI E, Kearney KE, Chung CJ, Elison D, et al
    Predicting Mortality and Periprocedural Adverse Events in Patients Undergoing Complex and Higher Risk Percutaneous Coronary Intervention.
    Can J Cardiol. 2025;41:1434-1442.
    PubMed     Abstract available
    
    
    
51. ABDELGHANI M, Hemetsberger R, Hassan A, Abdelshafy M, et al
    Acute Coronary Syndromes after Transcatheter Aortic Valve Implantation: Incidence, Unique Mechanisms, and Outcomes.
    Can J Cardiol. 2025;41:1628-1637.
    PubMed     Abstract available
    
    
    
52. GUPTA AK, Mustafiz C, Mutahar D, Zaka A, et al
    Machine Learning vs Traditional Approaches to Predict All-Cause Mortality for Acute Coronary Syndrome: A Systematic Review and Meta-analysis.
    Can J Cardiol. 2025;41:1564-1583.
    PubMed     Abstract available
    
    
    July 2025
53. ST JOHN PD, Bourgeois-Gosselin J, Tate RB
    Initial Presentation of Ischemic Heart Disease over the Life Course of Aging Men: The Manitoba Follow Up Study.
    Can J Cardiol. 2025 Jul 18:S0828-282X(25)00632.
    PubMed    
    
    
    
54. JAMHOUR-CHELH K, Jimenez-Kockar M, Fernandez-Peregrina E, Arzamendi D, et al
    Dissecting ST-elevation myocardial infarction pathophysiology through invasive physiology: Prognostic insight or actionable clinical guidance?
    Can J Cardiol. 2025 Jul 16:S0828-282X(25)00628.
    PubMed    
    
    
    
55. LI J, Xie P, Hu Y, Zhou Y, et al
    Predictive Value of Combining Angio-Based Index of Microcirculatory Resistance and Fractional Flow Reserve in Patients with STEMI.
    Can J Cardiol. 2025;41:1363-1371.
    PubMed     Abstract available
    
    
    June 2025
56. BROPHY JM
    The trials of interpreting clinical trials - A Bayesian perspective on colchicine following an acute coronary syndrome.
    Can J Cardiol. 2025 Jun 19:S0828-282X(25)00391.
    PubMed     Abstract available
    
    
    
57. SKALIDIS I, Akodad M, Neylon A, Garot J, et al
    Angiography-Derived Microvascular Dysfunction Evaluation in Patients with Diabetes and ST-Segment Elevation Myocardial Infarction.
    Can J Cardiol. 2025 Jun 11:S0828-282X(25)00387.
    PubMed    
    
    
    
58. BOUDREAU R, Chih S, Le May M, Di Santo P, et al
    Balancing Costs and Benefits: A Less DanGerous Protocol for Myocardial Infarction Complicated by Cardiogenic Shock.
    Can J Cardiol. 2025 Jun 10:S0828-282X(25)00383.
    PubMed    
    
    
    May 2025
59. WU Y, Liu J, Du X, Li M, et al
    Prognostic Value of Angiography-derived Index of Microcirculatory Resistance in Patients with diabetes and ST-Segment Elevation Myocardial Infarction.
    Can J Cardiol. 2025 May 9:S0828-282X(25)00334-4. doi: 10.1016/j.cjca.2025.
    PubMed     Abstract available
    
    
    
60. UZUN F, Guner A, Serin E, Alizade E, et al
    Mini-crush or Nano-crush Stenting Technique for Complex Coronary Bifurcation Lesions: the Multicenter MINANO Registry.
    Can J Cardiol. 2025;41:878-887.
    PubMed     Abstract available
    
    
    
61. DERIMAY F, Mercier A, Aminian A, Maillard L, et al
    Benefit of Systematic "Jailed Wire" Technique for Bifurcation Provisional Stenting. A CABRIOLET Substudy.
    Can J Cardiol. 2025;41:871-877.
    PubMed     Abstract available
    
    
    April 2025
62. MATTIUZZI C, Lippi G
    Mortality Risk of Acute Myocardial Infarction and Acute Myocarditis in COVID-19 and Influenza: A U.S. Nationwide Analysis Using Death Certificates.
    Can J Cardiol. 2025 Apr 29:S0828-282X(25)00327.
    PubMed    
    
    
    
63. GIN K, Wong GC, Greene DN
    Advancing risk stratification with a troponin-based universal algorithm for non-ST elevation myocardial infarction: Are we ready for a C change?
    Can J Cardiol. 2025 Apr 4:S0828-282X(25)00242-9. doi: 10.1016/j.cjca.2025.
    PubMed    
    
    
    
64. SACCHI S, Venuti A, Gobbi FM, Gambaro A, et al
    Clinical Prediction Score for Successful Liberation from Temporary Mechanical Circulatory Support in Cardiogenic Shock Patients.
    Can J Cardiol. 2025;41:730-739.
    PubMed     Abstract available
    
    
    
65. SO DYF, Boudreau R, Chih S
    The Role of a Cardiogenic Shock Team in Decision Making Surrounding Mechanical Circulatory Support.
    Can J Cardiol. 2025;41:682-690.
    PubMed     Abstract available
    
    
    
66. HUNG A, Slawnych M, McGuinty C
    Enhancing Care in Cardiogenic Shock: Role of Palliative Care in Acute Cardiogenic Shock Through Destination Therapy.
    Can J Cardiol. 2025;41:669-681.
    PubMed     Abstract available
    
    
    
67. BARKER M, van Diepen S, Granger CB, Wong GC, et al
    Differences in Care and Outcomes in Cardiogenic Shock in Cardiac Intensive Care Units in the United States and Canada: CCCTN Registry Insights.
    Can J Cardiol. 2025;41:718-727.
    PubMed     Abstract available
    
    
    
68. BRAHMBHATT DH, Kalra S, Luk A, Billia F, et al
    From Escalate to Elevate: A New Paradigm for Comprehensive Cardiogenic Shock Management.
    Can J Cardiol. 2025;41:630-644.
    PubMed     Abstract available
    
    
    
69. CHILLETTI R, Ihle J, Butt W
    Mechanical Circulatory Support for Septic Shock in Children and Adults: Different But Similar.
    Can J Cardiol. 2025;41:605-612.
    PubMed     Abstract available
    
    
    
70. YUEN T, Senaratne JM
    Definition, Classification, and Management of Primary Noncardiac Causes of Cardiogenic Shock.
    Can J Cardiol. 2025;41:587-604.
    PubMed     Abstract available
    
    
    March 2025
71. MARZOLINI S, Oh P, Peterman JE, Wallace P, et al
    Sex Differences and Correlates of the Utility of the Cardiopulmonary Exercise Test for Prescribing Exercise at Entry to Cardiac Rehabilitation.
    Can J Cardiol. 2025;41:481-490.
    PubMed     Abstract available
    
    
    February 2025
72. THIESSEN N, Pickering JW, Kellner C, Haller PM, et al
    A common algorithm for cardiac troponin to rule-out and rule-in acute myocardial infarction.
    Can J Cardiol. 2025 Feb 26:S0828-282X(25)00173.
    PubMed     Abstract available
    
    
    
73. BOUDREAU R, Le May M, Malhotra N, Clifford C, et al
    Evaluating Volume and Resource Needs for Implementing an ST-Elevation Myocardial Infarction Shock Protocol.
    Can J Cardiol. 2025 Feb 6:S0828-282X(25)00107-2. doi: 10.1016/j.cjca.2025.
    PubMed    
    
    
    
74. WANG J, Wang P, Liu H, Zhao Y, et al
    Impact of High-Sensitivity Cardiac Troponin I Elevation After On- and Off-Pump Coronary Artery Bypass Grafting on Long-Term Prognosis.
    Can J Cardiol. 2025;41:294-305.
    PubMed     Abstract available
    
    
    January 2025
75. WONG HJ, Toh KZX, Low CE, Yau CE, et al
    Guideline-Directed Medical Therapy in Nonagenarians and Centenarians (>/=90 Years Old) After First-Onset Myocardial Infarction - A National Registry Study.
    Can J Cardiol. 2025 Jan 31:S0828-282X(25)00101.
    PubMed     Abstract available
    
    
    
76. RANDHAWA VK, Baran DA, Kanwar MK, Hernandez-Montfort JA, et al
    The comparative epidemiology, pathophysiology and management of cardiogenic shock associated with acute myocardial infarction and advanced heart failure.
    Can J Cardiol. 2025 Jan 30:S0828-282X(25)00097.
    PubMed     Abstract available
    
    
    
77. LUK A, Barker M, Billia P, Fordyce CB, et al
    ECLS-SHOCK and DanGer Shock: Implications for optimal temporary mechanical circulatory support use for cardiogenic shock due to acute myocardial infarction.
    Can J Cardiol. 2025 Jan 15:S0828-282X(25)00014.
    PubMed     Abstract available
    
    
    
78. CHEN H, Adam A, Oudit GY
    Apelin analog reduces the burden of post myocardial infarction adverse remodeling: a new therapeutic approach for ischemic heart disease.
    Can J Cardiol. 2025 Jan 7:S0828-282X(25)00003-0. doi: 10.1016/j.cjca.2025.
    PubMed    
    
    
    
79. LAVERDURE M, Clifford CR, Barry Q, Knoll W, et al
    Can the Present Canadian Health Care System Provide Evidence-Based Pharmaceutical Care? Consideration of Two Important Cardiovascular Clinical Contexts.
    Can J Cardiol. 2025;41:60-67.
    PubMed     Abstract available
    
    
    
80. ZENG M, Chu M, Xu L, Yi B, et al
    Value of Combined Optical Coherence Tomography and Optical Flow Ratio Measurements After Percutaneous Coronary Intervention.
    Can J Cardiol. 2025;41:1-8.
    PubMed     Abstract available
    
    
    December 2024
81. GIRAULT-SOTIAS PE, Deloux R, De Mota N, Riche S, et al
    The metabolically resistant apelin-17 analog LIT01-196 reduces cardiac dysfunction and remodeling in heart failure after myocardial infarction.
    Can J Cardiol. 2024 Dec 12:S0828-282X(24)01258.
    PubMed     Abstract available
    
    
    
82. MISTRY N, Mazer CD, Sivaswamy A, Haldenby O, et al
    Transfusion in Anemic Patients With Acute Coronary Syndromes: A Population-Based Cohort Study.
    Can J Cardiol. 2024;40:2515-2524.
    PubMed     Abstract available
    
    
    November 2024
83. LONN A, Niyonsenga T, Carroll SJ, Bauman A, et al
    Physical activity and sedentary behaviour thresholds for secondary prevention of coronary heart disease: morbidity survival tree analysis.
    Can J Cardiol. 2024 Nov 29:S0828-282X(24)01230.
    PubMed     Abstract available
    
    
    
84. HIASA Y, Higaki A, Kamei Y, Nishikawa T, et al
    Impact of Aromatase Inhibitors Treatment Duration on Coronary Artery Calcification in Postoperative Patients With Breast Cancer.
    Can J Cardiol. 2024;40:2224-2230.
    PubMed     Abstract available
    
    
    
85. TAN MC, Dinh D, Gayed D, Liang D, et al
    Associations Between Dual Antiplatelet Therapy Score and Long-Term Mortality After Percutaneous Coronary Intervention: Analysis of More Than 27,000 Patients.
    Can J Cardiol. 2024;40:2045-2053.
    PubMed     Abstract available
    
    
    
86. EIKELBOOM JW, Yi Q, McIntyre WF, Bosch J, et al
    Results of the COMPASS Trial Analyzed Using Win Ratio Compared With Conventional Analytic Approaches.
    Can J Cardiol. 2024;40:2171-2179.
    PubMed     Abstract available
    
    
    
87. NARUI S, Yamamoto MH, Mori H, Amemiya K, et al
    Mechanism of Stent Failure in Patients With Eruptive Calcified Nodule Treated With Rotational Atherectomy.
    Can J Cardiol. 2024;40:1998-2007.
    PubMed     Abstract available
    
    
    
88. SIBBALD M, Cioffi GM, Shenouda M, McGrath B, et al
    Intravascular Imaging in the Diagnosis and Management of Patients With Suspected Intracoronary Pathologies: A CJC White Paper.
    Can J Cardiol. 2024;40:1977-1994.
    PubMed     Abstract available
    
    
    
89. DOAN VD, Zheng C, Onwuzurike J, Chen A, et al
    Prognostic Value of Stress Myocardial Perfusion Imaging Across the Spectrum of Cardiovascular Risk.
    Can J Cardiol. 2024;40:2205-2214.
    PubMed     Abstract available
    
    
    
90. SHAVADIA JS, Okpalauwaekwe U, Kim M, Orvold J, et al
    Contemporary Outcomes of Acute Coronary Syndromes in Indigenous Compared With Non-Indigenous Patients: A Northern Saskatchewan Perspective.
    Can J Cardiol. 2024;40:2094-2101.
    PubMed     Abstract available
    
    
    October 2024
91. ZHAO C, Lu P, Wang J, Liu Y, et al
    A Novel Therapy for the Failing Right Ventricle in Acute Myocardial Infarction: The First Reported Cases.
    Can J Cardiol. 2024 Oct 29:S0828-282X(24)01040.
    PubMed     Abstract available
    
    
    September 2024
92. AZZALINI L
    A New Kid on the Block in the Rapidly Evolving Landscape of Intravascular Lithotripsy: Novel Technologies for Challenging Calcified Coronary Lesions.
    Can J Cardiol. 2024;40:1668-1670.
    PubMed    
    
    
    
93. WANG Q, Ma W, Zhang D, Zhang W, et al
    Effectiveness and Safety of a Novel Intravascular Lithotripsy System for Severe Coronary Calcification: The CALCI-CRACK Trial.
    Can J Cardiol. 2024;40:1657-1667.
    PubMed     Abstract available
    
    
    
94. AGUILAR M
    My Big Fat Coronary Bypass Surgery: Sex, Obesity, and Postoperative Atrial Fibrillation.
    Can J Cardiol. 2024;40:1576-1579.
    PubMed    
    
    
    
95. DZAVIK V
    A Left Main Bifurcation Risk Score: Can It Safely Guide Our Choice of Bifurcation Stenting Technique?
    Can J Cardiol. 2024;40:1632-1634.
    PubMed    
    
    
    
96. HE J, Cai Z, Wang HY, Zhang R, et al
    A New Scoring System Predicting Side-Branch Occlusion in Patients Undergoing Left Main Bifurcation Intervention: The LM V-RESOLVE Score.
    Can J Cardiol. 2024;40:1619-1631.
    PubMed     Abstract available
    
    
    August 2024
97. SMILOWITZ NR
    Unresolved Controversies in Revascularization for Cardiogenic Shock with Acute Myocardial Infarction.
    Can J Cardiol. 2024 Aug 30:S0828-282X(24)00934.
    PubMed    
    
    
    
98. MARQUIS-GRAVEL G, Bhatia S, Brown V, Goodman SG, et al
    Care Gaps and System Issues With Delivering Cardiovascular Risk Reduction and Lipid-Lowering Therapy in Secondary Prevention.
    Can J Cardiol. 2024;40.
    PubMed     Abstract available
    
    
    July 2024
99. ROSTON TM, Aghanya V, Savu A, Fordyce CB, et al
    Premature Acute Myocardial Infarction Treated with Invasive Revascularization: Comparing STEMI to NSTEMI in a Population-Based Study of Young Patients.
    Can J Cardiol. 2024 Jul 9:S0828-282X(24)00521-X. doi: 10.1016/j.cjca.2024.
    PubMed     Abstract available
    
    
    
100. RIVARD A
     Real-World Treatment of In-Stent Restenosis: The Return of the Balloon.
     Can J Cardiol. 2024;40:1258-1260.
     PubMed    
     
     
     
101. AZZALINI L, Johal GS
     Complex and High-Risk Percutaneous Coronary Intervention at Centers With No Surgical Back-Up: Are We Ready for Prime Time?
     Can J Cardiol. 2024;40:1247-1249.
     PubMed    
     
     
     
102. DOOLUB G, Ly HQ, Marquis-Gravel G
     Should Rotational Atherectomy Be Used More Often in STEMI to Treat Calcified Culprit Lesions?
     Can J Cardiol. 2024;40:1234-1236.
     PubMed    
     
     
     
103. AZZALINI L, Kearney KE, Lombardi WL
     Intravascular Lithotripsy-Facilitated Balloon-Assisted Subintimal Entry for Chronic Total Occlusion Percutaneous Coronary Intervention.
     Can J Cardiol. 2024;40:1261-1263.
     PubMed    
     
     
     
104. SHAMKHANI W, Rashid M, Moledina S, Ludman P, et al
     Complex High-Risk Percutaneous Coronary Intervention Types, Trends, and Outcomes in Nonsurgical Centres.
     Can J Cardiol. 2024;40:1237-1246.
     PubMed     Abstract available
     
     
     
105. KHEIFETS M, Rahat O, Bental T, Levi A, et al
     Outcomes of Drug-Eluting Balloons for In-Stent Restenosis: Large Cohort Analysis and Single-Center Clinical Experience.
     Can J Cardiol. 2024;40:1250-1257.
     PubMed     Abstract available
     
     
     June 2024
106. PACHECO C, Coutinho T, Bastiany A, Beanlands R, et al
     Canadian Cardiovascular Society/Canadian Women's Heart Health Alliance Clinical Practice Update on Myocardial Infarction With No Obstructive Coronary Artery Disease (MINOCA).
     Can J Cardiol. 2024;40:953-968.
     PubMed     Abstract available
     
     
     
107. MOHAMED MO, Ghosh AK, Banerjee A, Mamas M, et al
     Socioeconomic and Ethnic Disparities in the Process of Care and Outcomes Among Cancer Patients With Acute Coronary Syndrome.
     Can J Cardiol. 2024;40:1146-1153.
     PubMed     Abstract available
     
     
     
108. LUU JM, Bairey Merz CN, Wei J
     Reply to Pendyal-Long-term Adverse Outcomes in Black Women With Obstructive Coronary Artery Disease: A Study of the Women's Ischemia Syndrome Evaluation (WISE) Cohort.
     Can J Cardiol. 2024;40:1177.
     PubMed    
     
     
     May 2024
109. LEE G, Malik A, Vervoort D, Tam DY, et al
     Revascularization in Left Ventricular Systolic Dysfunction: A Meta-Analysis of Kaplan-Meier Reconstructed Individual Patient Data.
     Can J Cardiol. 2024 May 30:S0828-282X(24)00414.
     PubMed     Abstract available
     
     
     April 2024
110. ROBERT YAO RJ, Fordyce CB
     Optimal transfusion threshold for anemic patients presenting with myocardial infarction and heart failure: dream or REALITY?
     Can J Cardiol. 2024 Apr 9:S0828-282X(24)00299-X. doi: 10.1016/j.cjca.2024.
     PubMed    
     
     
     
111. COURTNEY BK
     Very Late Stent Thrombosis in Japan: A Look Into the Future?
     Can J Cardiol. 2024;40:705-706.
     PubMed    
     
     
     
112. REA ABBAC, Mihajlovic V, Vishram-Nielsen JKK, Brahmbhatt DH, et al
     Pulmonary Artery Catheter Usage and Impact on Mortality in Patients With Cardiogenic Shock: Results From a Canadian Single-Centre Registry.
     Can J Cardiol. 2024;40:664-673.
     PubMed     Abstract available
     
     
     
113. MORI H, Sekimoto T, Arai T, Sakai R, et al
     Mechanisms of Very Late Stent Thrombosis in Japanese Patients as Assessed by Optical Coherence Tomography.
     Can J Cardiol. 2024;40:696-704.
     PubMed     Abstract available
     
     
     
114. DESSUREAULT A, Massie E, Fish D, Parent MC, et al
     Cardiomyopathy and Cardiogenic Shock Caused by Juvenile Hemochromatosis Improving With Guideline-Directed Medical Therapy Despite High Ferritin Levels.
     Can J Cardiol. 2024;40:662-663.
     PubMed    
     
     
     
115. AMJAD M
     High-Sensitivity Cardiac Troponin I Thresholds to Identify Myocardial Injury After Noncardiac Surgery.
     Can J Cardiol. 2024;40:734.
     PubMed    
     
     
     
116. GUERRA PG, Simpson CS, Van Spall HGC, Asgar AW, et al
     Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive.
     Can J Cardiol. 2024;40:500-523.
     PubMed     Abstract available
     
     
     March 2024
117. AKIOYAMEN LE, Ko DT, Cram P, Landon BE, et al
     Approaches to comparing the impact of socioeconomic disadvantage on acute myocardial infarction care within and across countries: a Scoping review.
     Can J Cardiol. 2024 Mar 26:S0828-282X(24)00274.
     PubMed     Abstract available
     
     
     
118. SAADA M, Lavi S
     Angiography-Derived Index of Microvascular Resistance: A New Frontier in the Management of Patients With Coronary Artery Disease.
     Can J Cardiol. 2024;40:444-446.
     PubMed    
     
     
     
119. CHEN L, Sang C, Wu Y, Chen W, et al
     Coronary Angiography-Derived Index of Microcirculatory Resistance Associated With New-Onset Atrial Fibrillation in Patients With STEMI.
     Can J Cardiol. 2024;40:434-443.
     PubMed     Abstract available
     
     
     
120. SHOWKATHALI R, Yalamanchi RP, Kumar AM, Cs V, et al
     Isolated Giant Right Coronary Aneurysm Associated With IgG4-Related Disease.
     Can J Cardiol. 2024;40:447-449.
     PubMed    
     
     
     
121. TSUNETA S, Suno K, Fujieda Y, Watanabe M, et al
     Accumulation of Technetium-99m Tetrofosmin on Myocardial Perfusion Scintigraphy in a Patient With Immunoglobulin G4-Related Coronary Periarteritis.
     Can J Cardiol. 2024;40:450-451.
     PubMed    
     
     
     February 2024
122. DUCROCQ G, Cachanado M, Simon T, Puymirat E, et al
     Restrictive vs Liberal Blood Transfusions for Patients with Acute Myocardial Infarction and Anaemia by Heart Failure Status: An RCT Subgroup Analysis.
     Can J Cardiol. 2024 Feb 24:S0828-282X(24)00179.
     PubMed     Abstract available
     
     
     October 2023
123. PELES I, Barrett O, Cafri C, Garcia-Garcia H, et al
     Predictors of Adverse Outcome in High-Risk Percutaneous Coronary Interventions Patients.
     Can J Cardiol. 2023;39:1369-1379.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum